【24h】

Ion channels and anti-cancer immunity

机译:离子通道和抗癌免疫力

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The outcome of a malignant disease depends on the efficacy of the immune system to destroy cancer cells. Key steps in this process, for example the generation of a proper Ca~(2+) signal induced by recognition of a specific antigen, are regulated by various ion channel including voltage-gated Kv1.3 and Ca~(2+)activated KCa3.1 K~+ channels, and the interplay between Orai and STIM to produce the Ca~(2+)-release-activated Ca~(2+) (CRAC) current required for T-cell proliferation and function. Understanding the immune cell subset-specific expression of ion channels along with their particular function in a given cell type, and the role of cancer tissue-dependent factors in the regulation of operation of these ion channels are emerging questions to be addressed in the fight against cancer disease. Answering these questions might lead to a better understanding of the immunosuppression phenomenon in cancer tissue and the development of drugs aimed at skewing the distribution of immune cell types towards killing of the tumour cells.
机译:恶性疾病的结果取决于免疫系统破坏癌细胞的功效。此过程中的关键步骤,例如通过识别特定抗原而诱导的适当Ca〜(2+)信号的产生,受各种离子通道的调控,包括电压门控的Kv1.3和Ca〜(2+)激活的KCa3 .1 K〜+通道,以及Orai和STIM之间的相互作用,以产生T细胞增殖和功能所需的Ca〜(2 +)-释放激活的Ca〜(2+)(CRAC)电流。理解离子通道的免疫细胞亚群特异性表达及其在给定细胞类型中的特定功能,以及癌症组织依赖性因子在调节这些离子通道操作中的作用,是在应对中的新兴问题。癌症疾病。回答这些问题可能会导致对癌症组织中免疫抑制现象的更好理解,以及旨在使免疫细胞类型的分布偏向杀死肿瘤细胞的药物的开发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号